IL17A and Alzheimer disease: PGN induced significantly higher mRNA expression of IL-17A and IL-22 in PBMCs of AD patients (Fig. 4a, c) while, both TLR2-ligands reduced the expression of IL-17F mRNA in PBMCs isolated from AD patients than that from healthy controls (Fig. 4b).